Comparison of the Xpert MTB/RIF Test with an IS 6110 -TaqMan Real-Time PCR Assay for Direct Detection of Mycobacterium tuberculosis in Respiratory and Nonrespiratory Specimens
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
The sensitivities of the Xpert MTB/RIF test and an in-house IS 6110 -based real-time PCR using TaqMan probes (IS 6110 -TaqMan assay) for the detection of Mycobacterium tuberculosis complex (MTBC) DNA were compared by use of 117 clinical specimens (97 culture positive and 20 culture negative for MTBC) that were frozen in sediment. The 97 clinical specimens included 60 respiratory and 37 nonrespiratory specimens distributed into 36 smear-positive and 61 smear-negative specimens. Among the 97 culture-positive specimens, 4 had rifampin-resistant isolates. Both methods were highly specific and exhibited excellent sensitivity (100%) with smear-positive specimens. The sensitivity of the Xpert MTB/RIF test with the whole smear-negative specimens was more reduced than that of the IS 6110 -TaqMan assay (48 versus 69%, P = 0.005). Both methods exhibited similar sensitivities with smear-negative respiratory specimens, but the Xpert MTB/RIF test had lower sensitivity with smear-negative nonrespiratory specimens than the IS 6110 -TaqMan assay (37 versus 71%, P = 0.013). Finally, the sensitivities of the Xpert MTB/RIF test and the IS 6110 -TaqMan assay were 79% and 84%, respectively, with respiratory specimens and 53% and 78%, respectively ( P = 0.013), with nonrespiratory specimens. The Xpert MTB/RIF test correctly detected the rifampin resistance in smear-positive specimens but not in the one smear-negative specimen. The Xpert MTB/RIF test is a simple rapid method well adapted to a routine laboratory that appeared to be as sensitive as the IS 6110 -TaqMan assay with respiratory specimens but less sensitive with paucibacillary specimens, such as smear-negative nonrespiratory specimens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“13 studies (839 samples; 10 with .10samples, 159 culture positive) evaluated Xpert in CSF against culture [14-16, 19, 20, 22-25, 27-29, 31].”
From Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis (2014) · cites this paper as [15]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rapid and simple method for purification of nucleic acids
Boom, R., Sol, C. J., Salimans, M. M., Jansen, C. L., Wertheim-van Dillen, P. M., & van der Noordaa, J. (1990) · Journal of Clinical Microbiology · doi:10.1128/jcm.28.3.495-503.1990 · Cited by 5,266 · cited 2×
“Smear-positive specimens (36) Respiratory (28) 28 0 0 0 Sputum (20) 20 0 0 0 Bronchial aspirate (4) 4 0 0 0 Gastric aspirate (4) 4 0 0 0 Nonrespiratory (8) 8 0 0 0 Lymph node (5) 5 0 0 0 Abscess (2) 2 0 0 0 Pleural fluid (1) 1 0 0 0”
MethodRapid Molecular Detection of Tuberculosis and Rifampin Resistance
Boehme, C. C., Nabeta, P., Hillemann, D., Nicol, M. P., Shenai, S., Krapp, F., Allen, J., Tahirli, R., Blakemore, R., Rustomjee, R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907847 · Cited by 2,309 · cited 5×
“In our study, the Xpert MTB/RIF test’s sensitivity with smear-negative respiratory specimens (57%) was found to be lower than that ( 72%) reported in recent studies performed with respiratory specimens (3, 9, 15, 16).”
BackgroundMethodResultInfluentialReal-Time PCR in Clinical Microbiology: Applications for Routine Laboratory Testing
Espy, M. J., Uhl, J. R., Sloan, L. M., Buckwalter, S. P., Jones, M. F., Vetter, E. A., Yao, J. D. C., Wengenack, N. L., Rosenblatt, J. E., Cockerill, F. R., et al. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.1.165-256.2006 · Cited by 1,318 · cited 2×
“The main advantages of real-time PCR are a shortened turnaround time; automation of the procedure, which reduces hands-on time; and a decrease in the risk of cross-contamination (6).”
Backgroundvan Soolingen, D., Hermans, P. W., de Haas, P. E., Soll, D. R., & van Embden, J. D. (1991) · Journal of Clinical Microbiology · doi:10.1128/jcm.29.11.2578-2586.1991 · Cited by 985 · cited 1×
“The better sensitivity of our in-house IS6110-TaqMan assay could be attributed to the effect of the multicopy target IS6110, which is present at 10 to 15 copies in most genomes of MTBC (7, 22).”
MethodHelb, D., Jones, M., Story, E., Boehme, C., Wallace, E., Ho, K., Kop, J., Owens, M. R., Rodgers, R., Banada, P., et al. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01463-09 · Cited by 914 · cited 7×
“Moreover, the similar sensitivities of the Xpert MTB/RIF test with fresh and frozen specimens were reported in analytic studies (9).”
BackgroundMethodResultInfluentialEvaluation of the analytical performance of the Xpert MTB/RIF assay
Blakemore, R., Story, E., Helb, D., Kop, J., Banada, P., Owens, M. R., Chakravorty, S., Jones, M., & Alland, D. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.00128-10 · Cited by 485 · cited 4×
“Smear-positive specimens (36) Respiratory (28) 28 0 0 0 Sputum (20) 20 0 0 0 Bronchial aspirate (4) 4 0 0 0 Gastric aspirate (4) 4 0 0 0 Nonrespiratory (8) 8 0 0 0 Lymph node (5) 5 0 0 0 Abscess (2) 2 0 0 0 Pleural fluid (1) 1 0 0 0”
MethodInfluentialRapid Molecular Detection of Extrapulmonary Tuberculosis by the Automated GeneXpert MTB/RIF System
Hillemann, D., Rüsch-Gerdes, S., Boehme, C., & Richter, E. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02268-10 · Cited by 413 · cited 1×
“have also recently reported a lower sensitivity of the Xpert MTB/RIF test with tissue specimens and suggested a preincubation step with proteinase K (10).”
BackgroundPai, M., Flores, L. L., Pai, N., Hubbard, A., Riley, L. W., & Colford, J. M. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00772-2 · Cited by 384 · cited 3×
“As would be expected, both methods were highly specific and exhibited excellent sensitivity for smear-positive specimens (respiratory and nonrespiratory specimens) but a reduced sensitivity for smear-negative specimens, a finding similar to the results of most previous studies (5, 12, 17, 18, 19, 21).”
BackgroundResultGlobal Tuberculosis Programme, & Disease, L. (1997) · Medical Entomology and Zoology · Cited by 361
Marlowe, E. M., Novak-Weekley, S. M., Cumpio, J., Sharp, S. E., Momeny, M. A., Babst, A., Carlson, J. S., Kawamura, M., & Pandori, M. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02214-10 · Cited by 253
Research works printed but not linked: 2
- 23. World Health Organization 2008. The WHO/IUATLD Global Project on antituberculosis-drug resistance surveillance. Publication no. WHO/HTM/TB/2008.394 World Health Organization, Geneva, Switzerland [[Google Scholar](https://scholar.google.com/scholar_lookup?World%20Health%20Organization%202008.%20The%20WHO/IUATLD%20Global%20Project%20on%20antituberculosis-drug%20resistance%20surveillance.%20Publication%20no.%20WHO/HTM/TB/2008.394%20World%20Health%20Organization,%20Geneva,%20Switzerland)] *
- 24. World Health Organization 2008. The WHO/IUATLD global tuberculosis control. Publication no. WHO/HTM/TB/2009.426 World Health Organization, Geneva, Switzerland [[Google Scholar](https://scholar.google.com/scholar_lookup?World%20Health%20Organization%202008.%20The%20WHO/IUATLD%20global%20tuberculosis%20control.%20Publication%20no.%20WHO/HTM/TB/2009.426%20World%20Health%20Organization,%20Geneva,%20Switzerland)]
Cited by
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
Steingart, K. R., Schiller, I., Horne, D. J., Pai, M., Boehme, C. C., & Dendukuri, N. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009593.pub3 · Cited by 1,102
Boehme, C. C., Nicol, M. P., Nabeta, P., Michael, J. S., Gotuzzo, E., Tahirli, R., Gler, M. T., Blakemore, R., Worodria, W., Gray, C., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60438-8 · Cited by 1,013
Denkinger, C. M., Schumacher, S. G., Boehme, C. C., Dendukuri, N., Pai, M., & Steingart, K. R. (2014) · European Respiratory Journal · doi:10.1183/09031936.00007814 · Cited by 527
Lawn, S. D., & Nicol, M. P. (2011) · Future Microbiology · doi:10.2217/fmb.11.84 · Cited by 486
“assessed the utility of Xpert for TB diagnosis in nonrespiratory samples, including pleural fluid, gastric fluid, tissue, cerebrospinal fluid, urine and stool [25,31,32].”
BackgroundResultInfluentialLawn, S. D., Mwaba, P., Bates, M., Piatek, A., Alexander, H., Marais, B. J., Cuevas, L. E., McHugh, T. D., Zijenah, L., Kapata, N., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70008-2 · Cited by 458
Zeka, A. N., Tasbakan, S., & Cavusoglu, C. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05434-11 · Cited by 362
“(2), our results with extrapulmonary specimens revealed 63% sensitivity for smear-negative specimens.”
BackgroundResultInfluentialNicol, M. P., Workman, L., Isaacs, W., Munro, J., Black, F., Eley, B., Boehme, C. C., Zemanay, W., & Zar, H. J. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70167-0 · Cited by 338
Scaling up interventions to achieve global tuberculosis control: progress and new developments
Raviglione, M., Marais, B., Floyd, K., Lönnroth, K., Getahun, H., Migliori, G. B., Harries, A. D., Nunn, P., Lienhardt, C., Graham, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60727-2 · Cited by 340
Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis
Tortoli, E., Russo, C., Piersimoni, C., Mazzola, E., Dal Monte, P., Pascarella, M., Borroni, E., Mondo, A., Piana, F., Scarparo, C., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00176311 · Cited by 322
“There is a large number of studies evaluating Xpert on pulmonary specimens [5,6,17-23]; the sensibility varies from 95 to 100% in smear-positive sputa, and from 47 to 77% in smearnegative ones.”
BackgroundXpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults
Horne, D. J., Kohli, M., Zifodya, J. S., Schiller, I., Dendukuri, N., Tollefson, D., Schumacher, S. G., Ochodo, E. A., Pai, M., & Steingart, K. R. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009593.pub4 · Cited by 267
“…Database of Systematic Reviews Study Reason for exclusion Alvis-Zakzuk 2017 Systematic review Andriani 2016 Abstract Antonenka 2013 Case-control study Armand 2011 This was a case-control study that compared Xpert MTB/RIF with an in-house IS6110-based real-time PCR using TaqMan probes…”
MethodInfluentialLawn, S. D., Brooks, S. V., Kranzer, K., Nicol, M. P., Whitelaw, A., Vogt, M., Bekker, L.-G., & Wood, R. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001067 · Cited by 278
Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF
Weyer, K., Mirzayev, F., Migliori, G. B., Van Gemert, W., D'Ambrosio, L., Zignol, M., Floyd, K., Centis, R., Cirillo, D. M., Tortoli, E., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00157212 · Cited by 256
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
Steingart, K. R., Sohn, H., Schiller, I., Kloda, L. A., Boehme, C. C., Pai, M., & Dendukuri, N. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009593.pub2 · Cited by 253
Xpert ® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance
Kohli, M., Schiller, I., Dendukuri, N., Dheda, K., Denkinger, C. M., Schumacher, S. G., & Steingart, K. R. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012768.pub2 · Cited by 245
Maynard-Smith, L., Larke, N., Peters, J. A., & Lawn, S. D. (2014) · BMC Infectious Diseases · doi:10.1186/s12879-014-0709-7 · Cited by 218
“text review, 55 papers were subsequently excluded, and 31 papers containing data on the diagnostic accuracy of Xpert MTB/RIF for TB when testing non-respiratory samples were reviewed in detail [12-38].”
BackgroundKohli, M., Schiller, I., Dendukuri, N., Yao, M., Dheda, K., Denkinger, C. M., Schumacher, S. G., & Steingart, K. R. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012768.pub3 · Cited by 215
El Khéchine, A., Couderc, C., Flaudrops, C., Raoult, D., & Drancourt, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024720 · Cited by 206
“Recently, confined real-time PCR has been shown to be effective for the rapid detection of tuberculosis, including rifampin-resistant tuberculosis, in respiratory tract specimens [13,14].”
Zifodya, J. S., Kreniske, J. S., Schiller, I., Kohli, M., Dendukuri, N., Schumacher, S. G., Ochodo, E. A., Haraka, F., Zwerling, A. A., Pai, M., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009593.pub5 · Cited by 179
Tuberculosis Diagnostics and Biomarkers: Needs, Challenges, Recent Advances, and Opportunities
McNerney, R., Maeurer, M., Abubakar, I., Marais, B., Mchugh, T. D., Ford, N., Weyer, K., Lawn, S., Grobusch, M. P., Memish, Z., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir860 · Cited by 191
Scott, L. E., McCarthy, K., Gous, N., Nduna, M., Van Rie, A., Sanne, I., Venter, W. F., Duse, A., & Stevens, W. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001061 · Cited by 171
“real-time PCR assay with 84% sensitivity [24]; the Xpert MTB/ RIF is suggested to be as good as the Gen-Probe MTB (GenProbe), but no data are available [25].”
MethodAgrawal, M. (2016) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2016/18837.7755 · Cited by 159
Sehgal, I. S., Dhooria, S., Aggarwal, A. N., Behera, D., & Agarwal, R. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.03205-15 · Cited by 134
“Seven studies performed Xpert MTB/RIF on frozen pleural fluid (7, 15, 19, 21, 23, 28, 30), while the remaining used fresh samples (see Table S4).”
MethodDiagnosis of extrapulmonary tuberculosis using the Xpert®MTB/RIF assay
Lawn, S. D., & Zumla, A. I. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.43 · Cited by 127
“It represents the largest number of nonrespiratory samples tested with Xpert MTB/RIF of any study published to date and provides a much larger number of EPTB diagnoses compared with most other studies, with the exception of the study from India by Vadwai and colleagues (Table 1) [6–12].”
ResultA multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay
Blakemore, R., Nabeta, P., Davidow, A. L., Vadwai, V., Tahirli, R., Munsamy, V., Nicol, M., Jones, M., Persing, D. H., Hillemann, D., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201103-0536oc · Cited by 118
Scott, L. E., Beylis, N., Nicol, M., Nkuna, G., Molapo, S., Berrie, L., Duse, A., & Stevens, W. S. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.03553-13 · Cited by 114
Barnard, M., van Pittius, N. C. G., van Helden, P. D., Bosman, M. E., Coetzee, G. J., & Warren, R. M. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01958-12 · Cited by 116
“In addition, this assay provides a rapid diagnosis of RIF resistance as a marker for multidrug-resistant TB (MDR-TB) (despite a number of falsepositive RIF resistance results having been observed) (2, 25) and thereby initiates a request for additional drug susceptibility testing (DST).”
MethodTheron, G., Peter, J., Meldau, R., Khalfey, H., Gina, P., Matinyena, B., Lenders, L., Calligaro, G., Allwood, B., Symons, G., et al. (2013) · Thorax · doi:10.1136/thoraxjnl-2013-203485 · Cited by 122
Perez-Risco, D., Rodriguez-Temporal, D., Valledor-Sanchez, I., & Alcaide, F. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.00659-18 · Cited by 103
Sohn, H., Aero, A. D., Menzies, D., Behr, M., Schwartzman, K., Alvarez, G. G., Dan, A., McIntosh, F., Pai, M., & Denkinger, C. M. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu022 · Cited by 95
“Yet, the performance of the test has not been studied in routine use in high-resource, tertiary-care settings with low incidence of tuberculosis [4, 5].”
BackgroundMoure, R., Martín, R., & Alcaide, F. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.06467-11 · Cited by 90
“The effectiveness of GX for diagnosing extrapulmonary TB has not been conclusively demonstrated, especially in countries with low or medium TB prevalence, since the system was initially validated only for respiratory specimens and most published studies include low numbers of extrapulmonary samples (1, 5, 9, 18).”
BackgroundTen Years of R&D and Full Automation in Molecular Diagnosis
Greub, G., Sahli, R., Brouillet, R., & Jaton, K. (2016) · Future Microbiology · doi:10.2217/fmb.15.152 · Cited by 89
Real-time PCR as a diagnostic tool for bacterial diseases
Maurin, M. (2012) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.12.53 · Cited by 101
Miller, M. B., Popowitch, E. B., Backlund, M. G., & Ager, E. P. C. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05212-11 · Cited by 77
“sensitivity for smear-positive pulmonary and extrapulmonary specimens and 68% and 71% sensitivities for smear-negative pulmonary and extrapulmonary specimens, respectively (1).”
BackgroundInfluentialDrobniewski, F. A., Nikolayevskyy, V., Михайловна, Б. Я., Bang, D., & Papaventsis, D. C. (2012) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.12.0180 · Cited by 90
Drobniewski, F. A., Nikolayevskyy, V., Maxeiner, H., Михайловна, Б. Я., Casali, N., Сергеевна, К. И., & Ignatyeva, O. A. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-190 · Cited by 78
“For TB diagnosis in sputum smear-positive samples, studies showed sensitivities ranging from 93% to 98% and specificities of 83% to 99% [13,14,23-25].”
BackgroundRapid diagnosis of tuberculosis using Xpert MTB/RIF assay - Report from a developing country
Yusuf, N. W., Iram, S., Zeenat, A., Hussain, S., & Aslam, M. (2014) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.311.6970 · Cited by 73
Diagnosing tuberculous meningitis – have we made any progress?
Ho, J., Marais, B. J., Gilbert, G. L., & Ralph, A. P. (2013) · Tropical Medicine & International Health · doi:10.1111/tmi.12099 · Cited by 65
Allahyartorkaman, M., Mirsaeidi, M. S., Hamzehloo, G., Amini, S., Zakiloo, M., & Nasiri, M. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-55112-y · Cited by 68
Molecular Logic Gates for DNA Analysis: Detection of Rifampin Resistance in M. tuberculosis DNA
Cornett, E. M., Campbell, E. A., Gulenay, G., Peterson, E., Bhaskar, N., & Kolpashchikov, D. M. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201203708 · Cited by 58
Babafemi, E. O., Cherian, B. P., Banting, L., Mills, G. A., & Kandala, N.-B. (2017) · Systematic Reviews · doi:10.1186/s13643-017-0608-2 · Cited by 63
“Armand, 2011 [26] France 70 47 LJ BacT/Alert MP TaqMan IS6110 gene”
BackgroundBunsow, E., Ruiz‐Serrano, M. J., López-Roa, P., Kestler, M., de Viedma, D. G., & Bouza, E. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.11.012 · Cited by 54
Yu, G., Zhong, F., Ye, B., Xu, X., Chen, D., & Shen, Y. (2019) · BioMed Research International · doi:10.1155/2019/4878240 · Cited by 52
Yao, X., Liu, Y., Liu, Y., Liu, W., Ye, Z., Zheng, C., & Ge, S. (2017) · Tuberculosis · doi:10.1016/j.tube.2017.07.013 · Cited by 48
Kumari, S. L., Reddy, D., Kumar, K., Rao, C. R. N. B., & Sanjana, P. H. (2019) · IP Indian Journal of Immunology and Respiratory Medicine · doi:10.18231/j.ijirm.2019.026 · Cited by 48
Al-Ateah, S. M., Al-Dowaidi, M. M., & El-Khizzi, N. A. (2012) · Saudi Medical Journal · doi:10.15537/1658-3175.5638 · Cited by 47
Piersimoni, C., Gherardi, G., Gracciotti, N., & Pocognoli, A. (2019) · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · doi:10.1016/j.jctube.2019.100094 · Cited by 50
“Although the results for smear-positive samples were within the range observed in high-incidence settings, sensitivity of the Xpert for smearnegative samples was found to be considerably lower than that previously reported ranging from 50% to 75% [9,10,11] and substantially comparable with other commercially available…”
ResultDiagnostic yield of CBNAAT in the diagnosis of extrapulmonary tuberculosis
Nishal, N., Arjun, P., Arjun, R., Ameer, K. A., Nair, S., & Mohan, A. (2022) · Lung India · doi:10.4103/lungindia.lungindia_165_22 · Cited by 45
Park, K., Kim, J., Lee, J. W., Hwang, Y.-Y., Jeon, K., Koh, W., Ki, C., & Lee, N. Y. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.01335-13 · Cited by 44
“This factor could explain why the sensitivity of the Xpert assay is lower than the sensitivities in the previous reports in which decontaminated samples were used (4, 5, 10, 11).”
ResultAntonenka, U., Hofmann-Thiel, S., Turaev, L., Esenalieva, A., Abdulloeva, M., Sahalchyk, E., Alnour, T. M. S., & Hoffmann, H. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-280 · Cited by 44
“Our findings might be explained by a certain benefit from the multi-copy target IS6110 used by DTB [14].”
BackgroundResultInfluentialUllah, I., Javaid, A., Masud, H., Ali, M., Basit, A., Ahmad, W., Younis, F., Yasmin, R., Khan, A., Jabbar, A., et al. (2017) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000449 · Cited by 41
“100%) in smear-positive pulmonary TB [7, 34–37] as compared to extrapulmonary specimens, where sensitivity is 37% in smear-negative and 100% in smear-positive specimens [34].”
BackgroundGong, X., He, Y., Zhou, K., Hua, Y., & Li, Y. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1149741 · Cited by 50
“characteristics of the 144 included studies from 107 articles (Armand et al., 2011; Causse et al., 2011; Friedrich et al., 2011; Ligthelm et al., 2011; Malbruny et al., 2011; Vadwai et al., 2011; Moure et al., 2012; Tortoli et al., 2012; Bates et al., 2013; Christopher et al., 2013; Porcel et al., 2013; Van Rie et al.…”
BackgroundDawany, N. B., Showe, L. C., Kossenkov, A. V., Chang, C., Ive, P., Conradie, F., Stevens, W. S., Sanne, I., Azzoni, L., & Montaner, L. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089925 · Cited by 50
Molecular Approaches for Detection of the Multi-Drug Resistant Tuberculosis (MDR-TB) in Bangladesh
Aurin, T. H., Munshi, S. K., Kamal, S. M. M., Rahman, M. M., Hossain, M. S., Marma, T., Rahman, F., & Noor, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099810 · Cited by 45
“tuberculosis isolates as well as to detect the resistance against RIF with a revelation of more than 95% sensitivity for smear-positive cases and 55% for smear-negative cases [24], [27], [28], [29], [30].”
BackgroundWassenberg, M. W. M., Kluytmans, J. A. J. W., Erdkamp, S., Bosboom, R. W., Buiting, A. G. M., van Elzakker, E., Melchers, W. J. G., Thijsen, S. F. T., Troelstra, A., Vandenbroucke‐Grauls, C. M. J. E., et al. (2012) · Critical Care · doi:10.1186/cc11184 · Cited by 41
Diagnosis of tuberculous meningitis: challenges and promises.
Philip, N., William, T., & John, D. V. (2015) · PubMed · Cited by 41
Khan, A. S., Ali, S., Khan, M. T., Ahmed, S., Khattak, Y., Abduljabbar, Irfan, M., & Sajjad, W. (2018) · Brazilian Journal of Microbiology · doi:10.1016/j.bjm.2018.02.011 · Cited by 39
Kolia-Diafouka, P., Carrère‐Kremer, S., Lounnas, M., BOURDIN, A. A., Kremer, L., de Perre, P. V., Godreuil, S., & Tuaillon, É. (2019) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2019.02.008 · Cited by 40
Shen, Y., Fang, L., Xu, X., Ye, B., & Yu, G. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.06.042 · Cited by 38
Aggarwal, A. N., Agarwal, R., Dhooria, S., Prasad, K. T., Sehgal, I. S., & Muthu, V. (2022) · PLoS ONE · doi:10.1371/journal.pone.0268483 · Cited by 39
“Ten investigators thawed cryopreserved fluid samples for their tests [23, 31, 35, 42, 60, 66, 73, 78, 80, 84].”
BackgroundAhmad, R., Changeez, M., Khan, J. S., Qureshi, U. M., Tariq, M., Malik, S., Ahmad, S. H., & Shafique, M. S. (2018) · Cureus · doi:10.7759/cureus.3451 · Cited by 34
Rapid Diagnosis of Mycobacterium tuberculosis Infection and Drug Susceptibility Testing
Wilson, M. L. (2013) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2011-0578-ra · Cited by 34
“A subsequent evaluation comparing the Xpert MTB/RIF assay against a laboratory-developed IS6110 polymerase chain reaction assay showed that it has high sensitivity (100%) for detection of M tuberculosis in smearpositive respiratory specimens, but again much lower sensitivity when used with smear-negative respiratory s…”
ResultYang, Q., Xu, Q., Chen, Q., Li, J., Zhang, M., Cai, Y., Liu, H., Zhou, Y., Deng, G., Deng, Q., et al. (2015) · Scientific Reports · doi:10.1038/srep17918 · Cited by 38
Scott, L. E., Gous, N. M., Cunningham, B., Kana, B. D., Perovic, O., Erasmus, L., Coetzee, G. J., KOORNHOF, H. J., & Stevens, W. S. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05167-11 · Cited by 35
Kokuto, H., Sasaki, Y., Yoshimatsu, S., Mizuno, K., Yi, L., & Mitarai, S. (2015) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofv074 · Cited by 32
“The Xpert Mycobacterium tuberculosis (MTB)/rifampicin (RIF) (Cepheid, Sunnyvale, CA) is a fully automated diagnostic test that allows for the detection of MTB and its RIF resistance, using real-time polymerase chain reaction (PCR) [1–5].”
MethodRapid Detection of the Mycobacterium tuberculosis Complex by Use of Quenching Probe PCR (geneCube)
Hida, Y., Hisada, K., Shimada, A., Yamashita, M., Kimura, H., Yoshida, H., Iwasaki, H., & Iwano, M. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01654-12 · Cited by 30
“that situation, more rapid diagnosis with genetic testing using PCR is now widespread 73 in hospital laboratories (1-3, 6-15, 17-21, 24, 26, 31).”
BackgroundKolia-Diafouka, P., Godreuil, S., BOURDIN, A. A., Carrère‐Kremer, S., Kremer, L., de Perre, P. V., & Tuaillon, É. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02224 · Cited by 34
“Two IS6110 PCRs were based on primers and probes previously reported (El Khéchine et al., 2009; Armand et al., 2011), in blue and red nucleic acid sequences (Figure 1 and Table 1).”
MethodTaylor, N., Gaur, R. L., Baron, E. J., & Banaei, N. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01012-12 · Cited by 28
“Unlike the results seen with tissue and stool samples, there was no significant PCR inhibition in the MTB/RIF assay with CSF and gastric aspirates.”
BackgroundInfluentialKurbatova, E. V., Kaminski, D. A., Ерохин, В. В., Volchenkov, G. V., Andreevskaya, S. N., Черноусова, Л. Н., Demikhova, O. V., Ershova, J. V., Kaunetis, N. V., Kuznetsova, T. A., et al. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-012-1798-0 · Cited by 27
“Others have speculated that the higher viscosity of unprocessed sputum may contribute to the indeterminate results when these types of specimens are tested with Xpert [18].”
Bulabula, A. N. H., Nelson, J. A., Musafiri, E. M., Machekano, R. N., Sam-Agudu, N. A., Diacon, A. H., Shah, M., Creswell, J., Theron, G., Warren, R. M., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy1105 · Cited by 27
Deggim, V., Somoskövi, Á., Voit, A., Böttger, E. C., & Bloemberg, G. V. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00151-13 · Cited by 27
“Previous studies showed a sensitivity of the Xpert MTB/RIF assay that varied between 46 and 77% in smear-negative and culture-positive specimens (7, 8, 15, 16, 17, 18).”
Sarah, T., & Souissi, N. (2016) · Molecular Biology Reports · doi:10.1007/s11033-016-4084-x · Cited by 27
Kabir, S., Uddin, M. K. M., Chisti, M. J., Fannana, T., Haque, M. E., Uddin, M. R., Banu, S., & Ahmed, T. (2018) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2018.01.015 · Cited by 28
Van Rie, A., Page-Shipp, L., Mellet, K., Scott, L., Mkhwnazi, M., Jong, E., Omar, T., Beylis, N., Stevens, W., Sanne, I., et al. (2013) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-1890-0 · Cited by 24
“While several studies have assessed the value of Xpert for extrapulmonary samples, only eight included FNA samples [12–19], of which three provided diagnostic performance estimates for FNA, with sensitivities ranging from 84.”
Pinhata, J. M. W., Cergole-Novella, M. C., Carmo, A. M. D. S., Silva, R. R. F. E., Ferrazoli, L., Sacchi, C. T., & de Oliveira, R. S. (2015) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000121 · Cited by 28
“000121 G 2015 The Authors Printed in Great Britain1040 Downloaded from www.microbiologyresearch.org by IP: 54.70.40.11 On: Sun, 04 Nov 2018 00:59:39 et al., 2003; Armand et al., 2011; Lira et al., 2013).”
BackgroundResultInfluentialA feasibility study of the Xpert MTB/RIF test at the peripheral level laboratory in China
Ou, X., Xia, H., Li, Q., Pang, Y., Wang, S., Zhao, B. T., Song, Y., Zhou, Y., Zheng, Y., Zhang, Z., et al. (2014) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2014.09.011 · Cited by 24
Sanjuán‐Jiménez, R., Morata, P., Bermudez, P. G., Bravo, M. J., & Colmenero, J. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002593 · Cited by 24
“6%) of the 24 extrapulmonary tuberculosis cases were smear-positive, a percentage similar to that reported by other authors [26,30].”
BackgroundResultComparison of Amplicor and GeneXpert MTB/RIF Tests for Diagnosis of Tuberculous Meningitis
Patel, V. B., Connolly, C., Singh, R., Lenders, L., Matinyenya, B., Theron, G., Ndung’u, T., & Dheda, K. U. J. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.01235-14 · Cited by 24
Patil, S. M., Narwade, S., & Mirza, M. (2017) · Journal of Translational Internal Medicine · doi:10.1515/jtim-2017-0030 · Cited by 23
Gene Xpert MTB/RIF assay for the diagnosis of intra-ocular tuberculosis from vitreous fluid samples
Sharma, K., Gupta, V., Sharma, A., Singh, R., Sharma, M., Aggarwal, K., Bansal, R., Fiorella, P. D., Prakash, S., & Gupta, A. (2016) · Tuberculosis · doi:10.1016/j.tube.2016.11.002 · Cited by 23
Choi, Y., Jeon, B., Shim, T. S., Jin, H., Cho, S.-N., & Lee, H. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.08.009 · Cited by 22
Rendell, N., Bekhbat, S., Ganbaatar, G., Dorjravdan, M., Pai, M., & Dobler, C. C. (2017) · PeerJ · doi:10.7717/peerj.3567 · Cited by 21
The Role of Genexpert in the Diagnosis of Mycobacterium tuberculosis
Sasikumar, C., Utpat, K. V., Desai, U. D., & Joshi, J. M. (2020) · Advances in respiratory medicine · doi:10.5603/arm.2020.0102 · Cited by 21
Xpert MTB/RIF test for detection of pulmonary tuberculosis and rifampicin resistance
Sohn, H., Pai, M., Dendukuri, N., Kloda, L. A., Boehme, C. C., & Steingart, K. R. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009593 · Cited by 20
You, Y., Ni, Y., & Shi, G. (2024) · Systematic Reviews · doi:10.1186/s13643-024-02733-8 · Cited by 20
“Mycobacterial culture, once considered as the “gold-standard” for TB diagnosis [6, 7], is time-consuming, prone to contamination, and requires further biochemical tests [8].”
Lira, L. A. S., Santos, F. C. F., Carvalho, M. S., Montenegro, R., Lima, J. F. C., Schindler, H. C., & Montenegro, L. M. L. (2012) · Journal of Applied Microbiology · doi:10.1111/jam.12119 · Cited by 20
“Many studies have reported a similar performance of IS6110-TaqMan assay to that found in our study (Broccolo et al. 2003; Lemâıtre et al. 2004; Armand et al. 2011; Yang et al. 2011).”
ResultAkhter, N., Sumalani, K. K., Chawla, D., & Rizvi, N. A. (2019) · ERJ Open Research · doi:10.1183/23120541.00065-2019 · Cited by 19
Zenteno‐Cuevas, R., Cuevas-Córdoba, B., Enciso, J. A., Enciso, L., & Cuellar, A. (2012) · Canadian Journal of Microbiology · doi:10.1139/w11-127 · Cited by 19
Pereira, G. R., Barbosa, M. S., Dias, N. J. D., de Almeida, C. P. B., & Silva, D. R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193988 · Cited by 18
To, K. W., Kam, K. M., Chan, D. P. C., Yip, W. H., Chan, K. P., Lo, R., Ng, S., Ngai, J. C. L., & Lee, S. S. (2018) · Journal of Infection · doi:10.1016/j.jinf.2018.06.011 · Cited by 17
Massi, M. N., Biatko, K. T., Handayani, I., Pratama, M. Y., Septriani, S., Nurdin, G. M., & Ali, M. B. (2017) · Journal of Orthopaedics · doi:10.1016/j.jor.2016.12.003 · Cited by 18
“This sensitivity value is similar to several reports.(11,17,21) However, the specificity value of GeneXpert MTB/RIF is considered low due to the high rate of false positive in this study, especially in several cases where the outcome of M.”
MethodResultMolecular Logic Gates for DNA Analysis: Detection of Rifampin Resistance in M. tuberculosis DNA
Cornett, E. M., Campbell, E. A., Gulenay, G., Peterson, E., Bhaskar, N., & Kolpashchikov, D. M. (2012) · Angewandte Chemie · doi:10.1002/ange.201203708 · Cited by 16
Performance of the Roche LightCycler Real-Time PCR Assay for Diagnosing Extrapulmonary Tuberculosis
Gous, N. M., Scott, L. E., Wong, E. B., Omar, T., Venter, F., & Stevens, W. S. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.00252-12 · Cited by 16
“Although the performance of the Xpert MTB/RIF has recently been reported for EPTB diagnosis (2, 4, 10, 11, 16, 31), this study also shows its potential application for solid tissue and warrants further investigation.”
MethodKandi, S., Reddy, V., & Nagaraja, S. B. (2017) · Pulmonary Research and Respiratory Medicine - Open Journal · doi:10.17140/prrmoj-4-137 · Cited by 16
Vinuesa, V., Navarro, D., Poujois, S., Zaragoza, S., & Borrás, R. (2015) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2015.11.001 · Cited by 16
“Several commercial systems using nucleic acid amplification detection methods have been developed and evaluated (Armand et al., 2011; Bloemberg et al., 2013; Causse et al., 2011; Chen et al., 2015; Cho et al., 2015; Friedrich et al., 2011; Kim et al., 2011; Miller et al., 2011; Park et al., 2013; Scott et al., 2011; T…”
MethodResultMycobacterium tuberculosis diagnosis from conventional to biosensor-a systematic review
Hasan, M. R., Anzar, N., Sharma, P., Singh, S., Hassan, H., Rawat, C., & Narang, J. (2022) · International Journal of Environmental & Analytical Chemistry · doi:10.1080/03067319.2022.2147427 · Cited by 16
El-Sharif, A., Afifi, S., Eldahshan, R. M., Rafeh, N. G., & Eissa, S. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03974.x · Cited by 15
Chapter 7: Extra-pulmonary tuberculosis
Barss, L., Connors, W. J. A., & Fisher, D. (2022) · Canadian Journal of Respiratory Critical Care and Sleep Medicine · doi:10.1080/24745332.2022.2036073 · Cited by 25
Gene Xpert MTB/RIF Assay: A New Hope for Extrapulmonary Tuberculosis
Raj, A. (2012) · IOSR Journal of Pharmacy (IOSRPHR) · doi:10.9790/3013-02108389 · Cited by 15
Parwati, I., Chaidir, L., Yunus, M., Montain, M. M., Budhiarko, D., Selasih, S. F., Ristandi, R. B., Rachman, R. W., Nurhayati, R. D., Pambudi, I., et al. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1372647 · Cited by 15
Herráez, Ó., Asencio-Egea, M. Á., Vaquero, M. H., Carranza-González, R., Castellanos-Monedero, J. J., Franco-Huerta, M., Barberá-Farré, J. R., & Tenías, J. M. (2016) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2016.06.009 · Cited by 11
Metadata
- Authors
- Armand, S., Vanhuls, P., Delcroix, G., Courcol, R., & Lemaître, N.
- Affiliations
- Centre Hospitalier Universitaire de Lille (FR)
- Centre National de la Recherche Scientifique (FR)
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2011-05
- Volume
- 49
- Issue
- 5
- Pages
- 1772-1776
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC3122654
- OpenAlex
- W2118461432
- Semantic Scholar
- 5845d45bf32e672c9e9ecfb3eb12687a563f3a8c
- Cited by
- 179
- References
- 26
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 6 · 2023: 4 · 2022: 9 · 2021: 8 · 2020: 7 · 2019: 11 · 2018: 18 · 2017: 13 · 2016: 11 · 2015: 12 · 2014: 19 · 2013: 18 · 2012: 26
- FWCI
- 16.47
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Keywords
- Mycobacterium tuberculosis complex, tuberculosis diagnosis, rifampicin resistance, diagnostic sensitivity
- MeSH terms
- Antitubercular Agents, Bacteriological Techniques, Humans, Mycobacterium tuberculosis, Rifampin, Sensitivity and Specificity, Tuberculosis, Drug Resistance, Bacterial, Molecular Diagnostic Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.